rjantz@cooley.com
Rick Jantz focuses on domestic and international transactional tax matters. He has advised public and private companies, private equity funds, financial institutions and non-profit organizations.
Download full bio
X4 Pharmaceuticals in its Exclusive License Agreement with Abbisko Therapeutics
GENFIT SA in its Licensing and Collaboration Agreement with Terns Pharmaceuticals
Vir Biotechnology - $143 Million IPO
Arlo to Partner with Verisure
Reata Pharmaceuticals – $505 Million Follow-On Offering
View all
Tax
Mergers & Acquisitions
Private Equity
New York University School of LawJD, Jacobson Scholar, 2015
University of California, Los AngelesBA, Business Economics2012
California
Meredith Agrees to Sell National Media Group to IAC’s Dotdash October 14, 2021
Snyk Hits $8.5 Billion Valuation With Series F Round September 15, 2021
Kredivo Agrees to SPAC Merger With VPC Impact Acquisition Holdings II August 4, 2021
+1 310 883 6493
Locations